BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 32043622)

  • 1. Diagnostic performance of reticulocyte hemoglobin equivalent in assessing the iron status.
    Chinudomwong P; Binyasing A; Trongsakul R; Paisooksantivatana K
    J Clin Lab Anal; 2020 Jun; 34(6):e23225. PubMed ID: 32043622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reticulocyte hemoglobin equivalent in a thalassemia-prevalent area.
    Kadegasem P; Songdej D; Lertthammakiat S; Chuansumrit A; Paisooksantivatana K; Mahaklan L; Wongwerawattanakoon P; Tangbubpha N; Sirachainan N
    Pediatr Int; 2019 Mar; 61(3):240-245. PubMed ID: 30593711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reticulocyte hemoglobin equivalent as a marker to assess iron deficiency: A large pediatric tertiary care hospital study.
    Poventud-Fuentes I; Chong TH; Dowlin M; Devaraj S; Curry CV
    Int J Lab Hematol; 2024 Feb; 46(1):148-155. PubMed ID: 37850393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reticulocyte hemoglobin equivalent as a potential marker for diagnosis of iron deficiency.
    Toki Y; Ikuta K; Kawahara Y; Niizeki N; Kon M; Enomoto M; Tada Y; Hatayama M; Yamamoto M; Ito S; Shindo M; Kikuchi Y; Inoue M; Sato K; Fujiya M; Okumura T
    Int J Hematol; 2017 Jul; 106(1):116-125. PubMed ID: 28299633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reticulocyte Hemoglobin vis-a-vis Serum Ferritin as a Marker of Bone Marrow Iron Store in Iron Deficiency Anemia.
    Mehta S; Goyal LK; Kaushik D; Gulati S; Sharma N; Harshvardhan L; Gupta N
    J Assoc Physicians India; 2016 Nov; 64(11):38-42. PubMed ID: 27805332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Indicator Derived From Reticulocyte Hemoglobin Content for Screening Iron Deficiency in an Area Prevalent for Thalassemia.
    Jamnok J; Sanchaisuriya K; Chaitriphop C; Sanchaisuriya P; Fucharoen G; Fucharoen S
    Lab Med; 2020 Sep; 51(5):498-506. PubMed ID: 32052840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of reticulocyte hemoglobin equivalent with traditional markers of iron and erythropoiesis in pediatric dialysis.
    Davidkova S; Prestidge TD; Reed PW; Kara T; Wong W; Prestidge C
    Pediatr Nephrol; 2016 May; 31(5):819-26. PubMed ID: 26667237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of measuring reticulocyte hemoglobin equivalent in the management of haemodialysis patients with iron deficiency.
    Miwa N; Akiba T; Kimata N; Hamaguchi Y; Arakawa Y; Tamura T; Nitta K; Tsuchiya K
    Int J Lab Hematol; 2010 Apr; 32(2):248-55. PubMed ID: 19624802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of iron deficiency in hemodialysis patients: Usefulness of measuring reticulocyte hemoglobin equivalent.
    Sany D; El Shahawi Y; Taha J
    Saudi J Kidney Dis Transpl; 2020; 31(6):1263-1272. PubMed ID: 33565438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Reticulocyte Hemoglobin Equivalent as a Marker for Iron Deficiency and Responsiveness to Iron Therapy.
    Auerbach M; Staffa SJ; Brugnara C
    Mayo Clin Proc; 2021 Jun; 96(6):1510-1519. PubMed ID: 33952394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reticulocyte Hemoglobin Equivalent has Comparable Predictive Accuracy as Conventional Serum Iron Indices for Predicting Iron Deficiency and Anemia in a Nonhuman Primate model of Infantile Iron Deficiency.
    Rao RB; Lubach GR; Ennis-Czerniak KM; Lock EF; Kling PJ; Georgieff MK; Coe CL
    J Nutr; 2023 Jan; 153(1):148-157. PubMed ID: 36913448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the hypochromic erythrocyte and reticulocyte hemoglobin content provided by the Sysmex XE-5000 analyzer in diagnosis of iron deficiency erythropoiesis.
    Buttarello M; Pajola R; Novello E; Mezzapelle G; Plebani M
    Clin Chem Lab Med; 2016 Dec; 54(12):1939-1945. PubMed ID: 27658146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Hemoglobin Content of Reticulocyte to Evaluate Anemia in Patients with Malignancy.
    Singh G; Chaudhry S; Kumawat A; Kumar G; Singh R
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reticulocyte Hemoglobin Equivalent (Ret-He) Combined with Red Blood Cell Distribution Width Has a Differentially Diagnostic Value for Thalassemias.
    Lian Y; Shi J; Nie N; Huang Z; Shao Y; Zhang J; Huang J; Li X; Ge M; Jin P; Wang M; Zheng Y
    Hemoglobin; 2019; 43(4-5):229-235. PubMed ID: 31476929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of the reticulocyte hemoglobin equivalent in the exclusion of latent iron deficiency.
    Bouzid G; Yousfi N; Hassine ZB; Daly F; Attoini A; Daoud N; Omar S; Salah NB
    Ann Biol Clin (Paris); 2023 Jul; 81(3):262-268. PubMed ID: 37329146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states.
    Brugnara C; Schiller B; Moran J
    Clin Lab Haematol; 2006 Oct; 28(5):303-8. PubMed ID: 16999719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovative parameters RET-Y, sTfR, and sTfR-F index in patients with microcytic, hypochromic anemia--their special value for hemoglobinopathies.
    Agorasti A; Trivellas T; Papadopoulos V; Konstantinidou D
    Lab Hematol; 2007; 13(2):63-8. PubMed ID: 17573284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordance between Reticulocyte Hemoglobin Equivalent and Reticulocyte Hemoglobin Content in CKD Patients Undergoing Hemodialysis.
    Wirawan R; Tedja AT; Henrika F; Lydia A
    Acta Med Indones; 2017 Jan; 49(1):34-40. PubMed ID: 28450652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta-He, Ret-He and a New Diagnostic Plot for Differential Diagnosis and Therapy Monitoring of Patients Suffering from Various Disease-Specific Types of Anemia.
    Weimann A; Cremer M; Hernáiz-Driever P; Zimmermann M
    Clin Lab; 2016; 62(4):667-77. PubMed ID: 27215087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reticulocyte hemoglobin equivalent: an indicator of reduced iron availability in chronic kidney diseases during erythropoietin therapy.
    Garzia M; Di Mario A; Ferraro E; Tazza L; Rossi E; Luciani G; Zini G
    Lab Hematol; 2007; 13(1):6-11. PubMed ID: 17353176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.